Substituted N-(1H-indazol-4-yl)imidazo1,2-apyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors

摘要

Compounds useful in the treatment of fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain and burns in a mammal.